Indii | 2023 Demo Day Pitch


Pete Beckett, Founder of Indii.


Indii is enabling independence for disabled and older people by unlocking the potential of the smart home.


[00:00 – 01:28] Pete

This is Sofii, the adaptable switch for your home.

And this is Sophie, my youngest sister. Sophie is a genuine ray of sunshine who finds her joy in good food and singing Christmas songs all year round. In 2001, Sophie experienced a severe brain trauma, and as a result, now requires one-to-one care on a daily basis. Sophie’s experience is what inspires our vision.

Hi, I’m Pete Beckett the founder of Indii and we’re developing technology to enable the tens of millions of people with motor disabilities who stand to benefit from integrating smart-home technology into their homes.

Currently, home tech is limited by its input devices. In a world ruled by phone apps, quick and universal control is not a given. Voice assistants have been a great step in the right direction, but there are many scenarios where users cannot or do not want to use their voice as a primary input method.

Meanwhile, companies operating in the assistive tech space excel in designing solutions with specific user requirements. Unfortunately, to date, most implementations of environmental control have been prohibitively expensive and limited in both scope and capability.

That’s what led us to develop Sofii, the switch, not the sister. Sofii supports adaptive switches and offers audio-visual feedback and connects directly to the smart home without the need for a mobile device.

[01:28 – 01:34] Sofii

This button controls your bedroom lights. Press the button again to toggle on and off.

[01:35 – 02:33] Pete

Sofii can act as a Bluetooth switch for iPads, phones and computers and at just $350, is more capable than its nearest Bluetooth-only rivals and for a lower price.

Over the past 18 months we’ve developed the hardware and software and tested with new potential users.

We’re now really close to delivering on our mission of providing new and improved ways to enable independence at home. But the next 18 months is set to be even more exciting. This spring we’re welcoming interested parties to evaluate our hardware and explore commercial partnerships as we move towards a launch, selling into the NDIS early next year. And this is just the beginning.

In the future, we want to take our tech out of the home and into public spaces, providing more convenient ways for our customers to interact with the world around them.

And all this thanks to Sofii, the switch and the sister.

The Care Co | 2023 Demo Day Pitch


Brianna MacDonald, Founder of The Care Co.


The Care Co teaches kids aged 5 to 12 mental health habits in the classroom and beyond.


[00:00 – 3:29] Brianna

I’d like you to imagine a primary school class. This might be your child’s class or a child you know and there could be about 30 kids.

If it’s a classroom of 30 kids, we expect about 1 in 5 of those children to have already experienced a traumatic event.

We expect 1 in 7 of those kids to already or soon to be struggling with their mental health.

And on average, about 1 in 10 of those young people is disabled.

I’m sure you can imagine, in a classroom of 30 children, that’s a lot of need. And unfortunately, it doesn’t stop there.

We know that 1 in 3 adults struggles with their mental health. We’re losing about $5 trillion in the workplace and 1 in 5 sick days for the same reason. Depression, anxiety and substance abuse disorder are three of the world’s leading disabilities. And it’s expected that almost all people will face at least one significantly traumatic event in their lifetime.

The problem isn’t just our declining level of mental health and wellbeing. The problem is that we’re not learning the skills needed to manage these challenges and we simply don’t have enough supply to meet the need.

My name is Brianna and I’m the founder of The Care Co. I’m a Canadian First Nations woman studying a Masters in Psychology with Harvard. I’ve worked in the trauma-informed education space, am a two-time entrepreneur, and 20 years ago, I was a Care Co kid. Now a flourishing, healthy adult, I’m just one example of what can be achieved with early intervention. And I spend a lot of time looking for where the opportunities are.

Chances are you or someone you know is a parent or guardian and you’re probably pretty busy. While you may not feel like a mental health expert, you’ve got one silver lining. Chances are you send your child to school. If you’re an educator, you might feel plagued with questions like, “How do I teach mental health in the classroom?” Again, an opportunity. You’re teaching fundamental life skills every day. Psychologists are a fantastic, effective model, and while they’re hard to scale in their current form, the psychology community gives us an evidence-based best-practice way to work with kids.

And this brings us to The Care Co. The Care Co is an in-classroom software that teaches kids between the ages of 5 and 12 mental health habits. A self-paced learning tool, we offer easy lesson planning, agency, and a unique way to build mental health habits from day one. One of the features we’re super proud of include our ability-based, evidence-based model,support for school disability funding reports, and activities that are mapped to health subject teaching needs. So where do we go from here?

We’re beta testing our app with 5 schools and 1,500 students. Next we’re partnering with the Cerebral Palsy Alliance and positioning The Care Co in front of about 1,200 schools in September 2023, and officially launch in October. Our future plans include the psychology,
disability and social work communities, as well as an app for parents and guardians at home.

And we have one really audacious goal – “every child, every school.”

To get there, we offer subscriptions priced per student per month. Schools can choose a 6-month or 12-month licence. And considering the 2 billion kids worldwide, we’re just getting started. First targeting 1 million students, we’ll be grossing $60 million in annual recurring revenue if we reach that goal.

For those ready to see mental health skills taught in every school, I ask that you scan this QR code to view a product demo, visit our website, or join our product updates and investment opportunity newsletters.

And if you’re onboard with our North star, join our mission. We would love to have you along.

SpineX | 2023 Demo Day Pitch


Kara Allanach, Director at SpineX.


SpineX is a clinical-stage bioelectric MedTech company committed to delivering spinal cord neuromodulation technologies to improve the lives of people with neurological conditions.


[00:00 – 04:05] Kara

Imagine if you or someone you love was unable to move their body as they pleased or control bladder function on their own. For millions of people in the US living with neurological conditions, this is their reality.

Here at SpineX, we are developing incredible new technology to treat these conditions by using electrical impulses to retrain the spinal cord. Our technology is built on groundbreaking research from the top scientists in the field of neuromodulation and is done non-invasively, without needles or surgery.

Although our technology has many potential applications, we have chosen to focus our first two commercial products on conditions with huge unmet clinical needs, movement disorder in children with cerebral palsy, or CP, and incontinence in adults with neurogenic bladder. These conditions together affect more than 2.5 million Americans.

Existing treatments are simply not good enough because they don’t fix the problems, they only reduce symptoms. At best, they’re short-term solutions, like drugs that cover up symptoms but have unmanageable side effects. And at worst, they’re invasive treatments, like Botox injections or nerve-severing surgery, causing irreversible long-term reductions in function.

With SpineX, now there is hope for these patients and their families. This is a three-year-old child with CP. Before SpineX, he was unable to take steps on his own but when we provided SpineX therapy, within five minutes, he was able to take steps. We have seen similar results, in line with their functional level, with nearly all of the more than 40 children who have undergone treatment with SpineX therapy so far. The really exciting part? We see durable improvements that last for several months beyond the final SpineX therapy treatment. Nothing else on the market can do this.

Neurogenic bladder, or NB, is common in spinal cord injury, multiple sclerosis and stroke. NB often involves incontinence, frequent urinary tract infections, loss of sleep from night-time voids, and use of catheters to empty the bladder. For some people, catheterisation can take 20 minutes each time and must be done anywhere from four to more than ten times per day, including several times through the night.

With SpineX therapy, we’re able to reduce incontinence episodes by 70%. And if leaks do happen, they’re smaller. Patients report feeling more in control, they don’t need as many catheters and they can finally sleep through the night.

How does it work? The common thread between all of these conditions is that messages between the brain and the spinal cord don’t get through clearly. SpineX acts like a hearing aid for the spinal cord, amplifying the signals that need to get through while cutting out background noise. We deliver special electrical pulses through the skin to rewire brain patterns and encourage neuroplasticity, producing long-term results.

What’s next? Our team of highly-experienced medtech professionals is excited to bring these technologies to market. We expect to receive FDA approval for and launch the first of our products in late 2024. We will reach our target customers by working directly with our collaborators in the hospitals, rehabilitation centres and physical therapy clinics where they are already being treated so that we can make sure that we reach as many potential users as possible.

We’ve been told by our patients and their families that the impact of our technology
is magical, and we agree.

Join us in our quest to bring this amazing technology to market. We’re launching a financing round, recruiting for clinical trials, and interested in talking to people with lived experience with any of these conditions.

Please reach out to us. We would love to talk to you.

Aurie | 2023 Demo Day Pitch


Souvik Paul, Founder and CEO of Aurie.


Aurie is building a reusable no-touch catheter system to help intermittent catheter users avoid urinary tract infections.


[00:00 – 03:24] Souvik

Nine years ago, my sister-in-law Carina sustained a spinal cord injury in a car accident. As she began her rehab, I learned that people with SCI would rather improve their bladder function than be able to walk again. That’s why I started Aurie. My name is Souvik Paul and our mission at Aurie is to prevent life-threatening infections for intermittent catheter users.

Carina is one of 600,000 people in the US who need to use six to eight single-use intermittent catheters a day. These catheters are basically plastic straws with holes on either end. To use them, users go into the bathroom, insert the catheter into the urethra and leave it in until urine stops flowing from the bladder. Afterwards, these catheters are removed and thrown away. And altogether, over $2 billion worth of catheters are purchased in the US every year.

The problem is that urinary tract infections are a leading cause of death for people with spinal cord injuries and other intermittent catheter users. There is a 50% annual chance of a severe complicated UTI due to the use of standard catheters. The average user experiences one to two UTIs a year, and an annual supply of these catheters is about $5,000. There are safer no-touch catheters that reduce infections by over 30% because of their insertion sleeves and introducer tips that reduce contact contamination. Because they cost almost $20,000 for an annual supply, they are covered for less than 7% of Medicare patients.

Aurie uses a tech-enabled approach to make intermittent catheterisation safer, more convenient and more sustainable. Our reusable no-touch catheters have the same features that help reduce UTIs, but are designed to be reused 100 times with our patented portable smart catheter case, which completely automates the cleaning, disinfection and lubrication of catheters with tap water and pre-packaged supplies.

When we surveyed catheter users, 81% wanted to switch to our system. Why? Because our system allows us to provide infection-reducing features of no-touch catheters at the same price point as standard catheters. We provide a cost-effective means to reduce urinary tract infections for our users.

We’ve demonstrated repeatable and robust disinfection efficacy with early prototypes at the University of Notre Dame. We’ve further developed the prototypes and are preparing for FDA submission in early 2024. We have four issued patents, one pending patent, and additional planned submissions. We have FDA sign-off on our testing strategy and the FDA has even granted us the Safer Technologies Designation after reviewing our early test data. We’re expecting expedited review once we do submit.

The team at Aurie has over 75 years of experience in healthcare, has commercialised 17 medical devices, and has sold over $50 million in durable medical equipment.

We have a broad coalition of support from investors like Lakehouse Ventures and grant-funders like the National Science Foundation and the National Institute of Disabilities, all of whom believe in our mission.

We’re always looking to connect with like-minded investors and innovators. Join us in making infections and preventable death a thing of the past for catheter users.

MEMORehab | 2023 Demo Day Pitch


Kyle Cortesi, Director at MEMORehab.


MEMORehab is an online platform on a mission to build better memory habits.


[00:00 – 03:33] Kyle

Hi, everyone. We are MEMORehab and our mission is to enhance the experience of cognitive rehabilitation so we can make it more accessible, supportive and data-driven. We are a post-revenue company looking for partners to help us increase our outreach and grow our platform.

Globally, one in six people will live with a neurological condition, resulting from things like stroke, epilepsy, traumatic brain injury and more. Sadly, many patients cannot access cognitive rehab due to the inability to travel independently, their distance from the clinic, or the lack of clinicians available with the time or space to run interventions.

Even when interventions are available, patients often lack the tools to practise newly-learned skills or establish new habits. And clinicians are often unable to monitor how their patients are engaging with the program outside the clinic, leaving them unable to provide support when it’s needed most.

At MEMORehab, we support both clinicians and patients through the rehabilitation journey. For clinicians, we allow them to reach patients from anywhere using telehealth and track their patients’ progress with data analytics. For patients, we help them better understand their condition by providing educational resources and reinforce newly-learned skills using computerised training and automatic reminders. Imagine the efficiency. Weekly, group-based telehealth sessions, practice with digital tools, and consistent feedback.

We have begun our journey by adapting a well-established, group-based memory intervention to our platform with over ten years of clinical research backing its efficacy. And in the future, we aim to expand our services by adapting additional well-established interventions to our delivery model.

Right now, we are working on several projects to support MEMORehab, like building a dedicated research platform to test our materials, training and education programs for clinicians via accredited workshops and seminars, and a clinician registry to help patients find the right professional.

Since our incorporation 2021, we have worked with organisations, universities and hospitals. For example, we have partnered with both local and international organisations in the neurological injury space. We have teamed up with universities such as Monash to conduct clinical research, showing that patients using our platform increased in several key areas related to memory. And we are proud to say that major hospitals, health districts and clinics across the country have purchased our annual licences, with dozens of patients successfully using MEMORehab.

Our team brings a wealth of passion and experience, including Laurie Miller, a clinical neuropsychologist with 30 years of experience, Kyle Cortesi, that’s me, with experience in program management, and Pranshu Midha, a skilled front-end developer.

Today, we’re seeking partners who believe in our vision. So if you can help us reach more clinicians, link them with patients, or add interventions to our platform, we would love to hear from you.

So if you are interested in joining us to revolutionise cognitive rehabilitation, use the QR code to visit our website and let’s schedule a call.

With MEMORehab, we’re not just imagining the future of cognitive rehabilitation, we’re building it.

Hominid X | 2023 Demo Day Pitch


Thane Hunt, Founder and CEO of Hominid X.


Hominid X develops transformative assistive grasping devices to help individuals with hand disabilities to gain greater functional independence.


[00:00 – 02:45] Thane

There’s probably an object next to you right now. Pick it up, but without squeezing your fingers. It’s impossible.

I’m Thane Hunt, founder and CEO of Hominid X. We build wearable tools that help people to reclaim the use of their hands. Why?

Because there are over 200 million people who can’t use their hands, making everyday tasks difficult or impossible. Physical therapy can help, but often takes years and won’t result in a full recovery. And in the meantime, the adaptive solutions are either specialised to one task or too expensive.

So we designed Fiber, our easy-to-use, adaptive grasping tool that empowers its user with a secure and versatile grip around almost any object. A user can put it on in under 30 seconds and wear it comfortably all day to help them complete any task that requires grip strength. Our design guides the hand into a variety of different grasps, and it does this without any cumbersome motors or batteries. That’s right, our solution is entirely mechanical. There is no other product like it and we’re patent-protected.

Our early testers have held thousands of different objects and the results are clear. People with hand disabilities are riding bicycles, preparing food and getting back to doing what they love.

Let’s take an example, Megan, who loves to bake. Megan suffered a stroke when she was younger and lost the ability to use her left hand. When we met, she was using just one hand for her baking projects. Now with Fiber, she’s using both hands. She’s been able to focus more on her recipes and less on her grasp. She recently opened a bakery and summed up the magic of her experience with Fiber to her followers on TikTok.

[01:34 – 01:42] Megan

Dude, it works! I did it! Easy-peasy. Oh, this makes me so happy! I haven’t been able to do this for years.

[01:42 – 02:39] Thane

Stories like Megan’s are everywhere. Millions of people needed help with grasping and holding and they haven’t been served until now. We sell our products directly to the users or through their occupational therapists.

Since launching Fiber last year, we’ve worked with clinicians and users all across the United States. Once someone wears Fiber, they understand.

We have a strong team. With my background in prosthetics and hardware development, I invented Fiber. My co-founder, Soniya, did the marketing for a $200 million revenue business. And our manufacturing leader, Junior, brings 20 years of experience in scaling new products to mass production.

Try to imagine someone you care about being unable to pick up the phone when you call or giving up on their hobby because they lack the grip strength to do it. With Fiber, we’ve already been able to put the most fulfilling moments of people’s lives back into their own hands.

So visit us online at HominidX.com to purchase Fiber or to schedule a demo. And together, we’ll create a world where no hand is left behind.

Thank you.

Possibility Neurotechnologies | 2023 Demo Day Pitch


Dion Kelly, Co-Founder and CEO of Possibility Neurotechnologies.


Possibility Neurotechnologies is bridging the gap between BCI and everyday life, empowering individuals to control the world around them with just their thoughts.


[00:00 – 04:08] Dion Kelly

I’m Dion Kelly, Co-Founder and CEO of Possibility Neurotechnologies, the company that’s empowering the future of inclusion with our assistive technology solutions that convert thought to action.

This is Claire. Claire is a six-year-old girl with quadriplegic cerebral palsy. She can’t speak or move, which hinders her ability to use current assistive technologies. Though she’s very smart and capable, her physical limitations often make it difficult for her to communicate and express her abilities. Around the world, there are millions of children like Claire who face similar challenges. Their access to basic human rights, including self-expression, play and independence, is often restricted.

Brain Computer Interfaces, or BCIs, allow users to control devices using their brainwaves, including household appliances and power mobility chairs. However, BCIs and their applications are not yet readily available to the end-users like Claire because the middle component enabling control of these external devices has been confined to research environments.

Our proprietary technology, the Think2Switch, fills this gap in providing a bridge between BCIs and the devices that they can control. Using a BCI headset, a user can think about a desired intention and use that thought to control a switch-adapted device through translation of the thought to action by the Think2Switch.

We’re packaging our Think2Switch with a commercial BCI headset and environmental control device to provide a ready-to-use, plug-and-play solution for children to immediately access their environments and participate in life activities.

We’ve innovatively filled a significant gap in the market with our user-friendly, portable Think2Switch system. Unlike existing middleware solutions that are typically restricted to lab environments, our unique system is portable and ready for immediate plug-and-play application.

Our initial target market is children with quadriplegia, of which there are 36,000 resulting from CP in developed countries alone. Our entry into this market will leverage specialised healthcare networks, therapeutic communities and targeted marketing strategies. Subsequently, we plan to expand our reach to adults with quadriplegia, a demographic of more than nine million individuals in developed countries. This will involve partnerships with rehabilitation centres, adult care facilities and relevant healthcare providers.

Our long-term strategy involves penetrating the mass market of able-bodied children, a demographic of approximately 80 million in North America. In this phase, we’ll leverage mainstream retail channels and broad-based marketing strategies.

With our Think2Switch technology, Claire is actively participating in activities that were once impossible, from baking cookies with her little brothers, to blending her own meals, making lemonade, and even participating in their family tradition of pickling. Claire’s mom said, “It’s a light at the end of the tunnel. The possibilities are endless.”

As one of the few teams globally focused on researching BCIs for children, our multidisciplinary group of clinicians, engineers and business development specialists are leading the way in this untapped market.

With a shared passion for making a difference, we’re driving forward the development of integrated BCI solutions. We believe that everyone deserves equal opportunities and our vision is to foster an inclusive society where this is possible.

Our next goal is to significantly expand access to our product to better serve our primary target market of children with quadriplegia. In order to achieve this, we’re planning to raise a $2 million funding round later this year.

If you’re a passionate investor who shares our vision of an inclusive society, we’d love to start a conversation. We’re also interested in connecting with potential partners and customers who could benefit from our technology. With your support, we can bring BCI to the millions of individuals who need it most.

Let’s work together to create a future where everyone, regardless of their physical abilities, has the chance to express themselves, to play, to create and to live independently.

Are you ready to join us on this journey?

Enabled Play | 2023 Demo Day Pitch


Alex Dunn, Founder and CEO of Enabled Play.


Enabled Play* levels the playing field for people with disabilities by giving them new ways to control their technology that works for them.

*Please note Enabled Play will soon be rebranding. 


[00:00 – 01:26] Alex

Hi, I’m Alex Dunn, the founder of Enabled Play, the platform that integrates personalised and accessible controls to help brands reach and support more customers of all abilities.

We got started building AI-augmented controls because in 2020, my brother Bryan was trying to keep up with his friends while playing video games, but he was getting left behind. And as an AI engineer and former founder, I knew there had to be a simple fix for this, a new way to communicate with devices and software that adapt to the individual rather than pushing them to depend on hardware that isn’t accessible or equitable to them. And it got us thinking.

Because the truth is that over 600 million people globally cannot access technology because simple software is not designed for their accessibility needs. Here in the US, that’s nearly one in five Americans. And as 91% of businesses now expect their customers to engage with their business in a software-first platform, it means they’re leaving behind 600 million potential customers. As an example, for one of our customers, a Fortune 50 bank, they estimate that there is more than 12 million unbanked or underbanked prospect customers in the US alone who cannot become their customer because their applications are not accessible. That’s money that they, and anyone else who is trying to reach more customers, is leaving on the table. In fact, we estimate that enterprise businesses are leaving on average $33 billion in revenue by not building for accessibility.

So we built Enabled Play, a personalised set of controls for users that let them augment and automate their technology with voice controls, face expressions, body gestures, motion controls, virtual buttons and more.

[01:37 – 01:41] Computer

New slide. Type this is my new title.

[01:41 – 02:30] Alex

It’s a platform that adapts to each user’s abilities using the latest innovations in AI and machine learning. Even more importantly, it can also operate entirely offline, so your voice and video is never recorded, it’s never streamed and it’s never shared beyond the device you’re using. Finally, it allows each user to bring their personalised profiles and preferences to each app, game and service they want to control, which means businesses don’t have to find the right way to support each unique user’s needs and preferences. They’ve already been empowered to do that for themselves and can bring those preferences and controls directly to your apps, games, websites and services. It also provides a new surface for your business’s services to be discovered, too.

We recently finished raising our seed investment round and are not looking for additional investors at this point, but we’re eager to meet with heads of accessibility, DE&I and technology working at companies that are eager to discover how, through a simple software integration with our platform, they can gain access to hundreds of millions of new users, too.

Virtetic | 2023 Demo Day Pitch


Ricardo Garcia-Rosas, Co-Founder and CEO of Virtetic.


Virtetic is empowering the prosthetics community through virtual reality.


[00:00 – 03:03] Ricardo

If you were to get a leg or an arm amputated, you’d need to wait over four months to get access to a prosthesis. While you wait, you lose function in the affected limb and become more at risk of suffering phantom limb pain throughout your life. This time delay costs healthcare systems around the world over $5 billion every year.

I’m Ricardo, co-founder and CEO of Virtetic, a digital health company enabling people to kick-start their journey with a prosthesis through the power of games and immersive technologies. By practising with a virtual prosthesis, people can start functional rehabilitation and learn to use a prosthesis as soon as they can start with therapy.

We co-design our gamified clinical interventions with the community to ensure they are evidence-based and representative of living with a prosthesis. Ultimately, our products help people to be able to fully use their prosthesis from day one.

Our first product, Myo-Hand XP, allows people to learn to use a prosthetic hand through guided practice in VR. Our second product helps people manage their phantom limb pain through active limb visualisations in VR. Our products can be used in the clinic or at home as prescribed by a qualified clinician, which can be covered by disability insurance, like the NDIS, TAC and iCare.

Virtetic provides all the hardware, software, training and support that both clinicians and their patients need to use our products. We partner with prosthesis manufacturers to feature their products within our system, helping them reach potential customers at an earlier stage.

That is why for the past two years, the number one prosthesis manufacturer, Ottobock, has been collaborating with us to incorporate their products into our system.

We have submitted the regulatory application in Australia for our first product, and we plan to submit the application for the second product in the first quarter of next year. We work with two clinics in Melbourne who are ready to pilot our products to validate their clinical effectiveness and the business model of our offering. These pilots will inform our commercial roll-out throughout Australia and how we can work with Ottobock to bring our offerings to the world.

We are a diverse and passionate team with a wealth of experience in the development and research of virtual reality and prosthetic devices, complemented by expertise in finance and management consulting. Our clinical advisors are expert clinical practitioners and world-leading researchers in prosthetics, rehabilitation and pain science. Our commercialisation advisors are global leaders in the commercialisation of medical devices.

But most importantly, we share a passion about making a positive impact in the lives of people living with limb loss. Following regulatory approval, we will launch our first product with partner clinics. To help drive revenues and growth, we’ll be seeking further capital in the next six months to scale our product offerings in Australia. If you are interested in joining us, please reach out.

Springrose | 2023 Demo Day Pitch


Nicole Cuervo, Founder and CEO of Springrose.


Springrose designs adaptive intimate apparel that improves quality of life for women with limited mobility.


[00:00 – 02:50] Nicole

My grandmother Rose was an unstoppable woman but she had chronic pain and arthritis that made it challenging to get dressed in the morning. And she’s not alone. In the US, one in three adult women has some form of limited mobility. That’s because there are 50 different injuries, illnesses and disabilities that affect women of all ages and impact their ability to get dressed painlessly and independently. Everything from a temporary broken bone or frozen shoulder to more permanent things like arthritis, MS, stroke and cerebral palsy. Bras are a particularly acute problem. That’s because traditional bras require two hands, high dexterity to connect the hooks, and the ability to move your shoulders behind you.

Hi, I’m Nicole Cuervo, founder and CEO of Springrose. We design adaptive intimate apparel to improve quality of life for women with limited mobility. We’ve designed an adaptive bra that gives women back their time, their dignity and their independence. It can be put on multiple different ways, including with one hand, or with limited dexterity or two bad shoulders by putting it overhead or stepping into it. 

Adaptive apparel is expected to reach $400 billion by 2026 worldwide. North America is responsible for 46% of that, so the opportunity is there. And we know women want this because on ad tests, we had ten times the click-through rate at one fifth of the cost of industry averages. And that’s because there’s no good solution on the market right now. Currently, women must compromise. They have to compromise on functionality, comfort, attractiveness, sizing, or safety with pacemakers and other health implants. 

With us, there is no compromise. And here are some comments from women who tried our product. Pamela mentions how she loved having something easy to take off at the end of the day when she had a flare up from a multiple sclerosis. Suzanne enjoyed the flexibility and the design, because with her chronic pain, she doesn’t know how she’s gonna wake up some days. And Libby mentioned how comfortable the bra was, which is what customers care the most about in our survey tests. 

As such, our go-to-market strategy is threefold. First, we’re investing in search and digital ads, which we have already done really well in, and there are specific long-tail keywords that people are looking for, such as “bra for women with arthritic hands” and “bra for stroke survivors” that apply to us. We’re also partnering with physical and occupational therapists across the country so they can recommend our product to their patients. And we are doing pop-ups around senior living and retirement communities because we know that 84% of apparel purchases still happen through a combination of online and in-person. We launched with pre-orders in May and already have sales. And we’re launching fully in market at the end of summer. 

I hope you’ll join us in improving quality of life for millions of people. You can buy our bra for yourself or a loved one, and if you’re a clinician, you can email me to set up a demo and get your free samples, or you can connect with me and we can figure out how else we can partner. Thank you so much.